Pfizer to buy rest of Biohaven for $11.6B
May 10, 2022 at 12:16 PM EDT
Pfizer Inc. agreed to buy the rest of Biohaven Pharmaceutical Holding Co. for about $11.6 billion, deploying its pile of cash earned from Covid-19 sales to acquire a new migraine drug.
